These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Natural killer cell subsets in cerebrospinal fluid of patients with multiple sclerosis. Rodríguez-Martín E; Picón C; Costa-Frossard L; Alenda R; Sainz de la Maza S; Roldán E; Espiño M; Villar LM; Álvarez-Cermeño JC Clin Exp Immunol; 2015 May; 180(2):243-9. PubMed ID: 25565222 [TBL] [Abstract][Full Text] [Related]
8. Role of natural killer cells in the pathogenesis and progression of multiple sclerosis. Morandi B; Bramanti P; Bonaccorsi I; Montalto E; Oliveri D; Pezzino G; Navarra M; Ferlazzo G Pharmacol Res; 2008 Jan; 57(1):1-5. PubMed ID: 18182304 [TBL] [Abstract][Full Text] [Related]
9. Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulation. Gross CC; Schulte-Mecklenbeck A; Rünzi A; Kuhlmann T; Posevitz-Fejfár A; Schwab N; Schneider-Hohendorf T; Herich S; Held K; Konjević M; Hartwig M; Dornmair K; Hohlfeld R; Ziemssen T; Klotz L; Meuth SG; Wiendl H Proc Natl Acad Sci U S A; 2016 May; 113(21):E2973-82. PubMed ID: 27162345 [TBL] [Abstract][Full Text] [Related]
10. Role of NK cells and invariant NKT cells in multiple sclerosis. Sakuishi K; Miyake S; Yamamura T Results Probl Cell Differ; 2010; 51():127-47. PubMed ID: 19582416 [TBL] [Abstract][Full Text] [Related]
11. ILC3, a Central Innate Immune Component of the Gut-Brain Axis in Multiple Sclerosis. Miljković Đ; Jevtić B; Stojanović I; Dimitrijević M Front Immunol; 2021; 12():657622. PubMed ID: 33912185 [TBL] [Abstract][Full Text] [Related]
12. NK Cells in HIV-1 Infection: From Basic Science to Vaccine Strategies. Flórez-Álvarez L; Hernandez JC; Zapata W Front Immunol; 2018; 9():2290. PubMed ID: 30386329 [TBL] [Abstract][Full Text] [Related]
13. The Role of NK Cells and Innate Lymphoid Cells in Brain Cancer. Sedgwick AJ; Ghazanfari N; Constantinescu P; Mantamadiotis T; Barrow AD Front Immunol; 2020; 11():1549. PubMed ID: 32903717 [TBL] [Abstract][Full Text] [Related]
14. CD3 Tahrali I; Kucuksezer UC; Akdeniz N; Altintas A; Uygunoglu U; Aktas-Cetin E; Deniz G Immunol Lett; 2019 Dec; 216():63-69. PubMed ID: 31589897 [TBL] [Abstract][Full Text] [Related]
15. Adaptive Features of Natural Killer Cells in Multiple Sclerosis. Moreira A; Alari-Pahissa E; Munteis E; Vera A; Zabalza A; Llop M; Villarrubia N; Costa-García M; Álvarez-Lafuente R; Villar LM; López-Botet M; Martínez-Rodríguez JE Front Immunol; 2019; 10():2403. PubMed ID: 31681293 [TBL] [Abstract][Full Text] [Related]
17. Viral Evasion of Natural Killer Cell Activation. Ma Y; Li X; Kuang E Viruses; 2016 Apr; 8(4):95. PubMed ID: 27077876 [TBL] [Abstract][Full Text] [Related]
18. Emerging insights into natural killer cells in human peripheral tissues. Björkström NK; Ljunggren HG; Michaëlsson J Nat Rev Immunol; 2016 Apr; 16(5):310-20. PubMed ID: 27121652 [TBL] [Abstract][Full Text] [Related]
19. CD27 natural killer cell subsets play different roles during the pre-onset stage of experimental autoimmune encephalomyelitis. Gao M; Yang Y; Li D; Ming B; Chen H; Sun Y; Xiao Y; Lai L; Zou H; Xu Y; Xiong P; Tan Z; Gong F; Zheng F Innate Immun; 2016 Aug; 22(6):395-404. PubMed ID: 27368310 [TBL] [Abstract][Full Text] [Related]
20. Metabolism of Natural Killer Cells and Other Innate Lymphoid Cells. Cong J Front Immunol; 2020; 11():1989. PubMed ID: 32983138 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]